E-LIB Suche - Ergebnisse für: Thompson, AJ

1

Bringing Molecular Diagnostic Tests Into Clinical Practice:..:

Thompson, AJ ; Allen, AJ ; Bouttell, J...
Value in Health. 20 (2017) 9 - p. A707 , 2017

Link: https://doi.org/10.1016/..

2

Assessing The Cost-Effectiveness Of The Manchester Acute Co..:

Thompson, AJ ; Lecky, F ; Body, R
Value in Health. 20 (2017) 9 - p. A587-A588 , 2017

Link: https://doi.org/10.1016/..

3

Discriminating between 5‐HT3A and 5‐HT3AB receptors:

Thompson, AJ ; Lummis, SCR
British Journal of Pharmacology. 169 (2013) 4 - p. 736-747 , 2013

Link: https://doi.org/10.1111/..

4

Grey matter damage and overall cognitive impairment in prim..:

Tur, C ; Penny, S ; Khaleeli, Z...
Multiple Sclerosis Journal. 17 (2011) 11 - p. 1324-1332 , 2011

Link: https://doi.org/10.1177/..

5

A comprehensive assessment of cerebellar damage in multiple..:

Anderson, VM ; Wheeler-Kingshott, CAM ; Abdel-Aziz, K...
Multiple Sclerosis Journal. 17 (2011) 9 - p. 1079-1087 , 2011

Link: https://doi.org/10.1177/..

6

Brain lesion location and clinical status 20 years after a ..:

Dalton, CM ; Bodini, B ; Samson, RS...
Multiple Sclerosis Journal. 18 (2011) 3 - p. 322-328 , 2011

Link: https://doi.org/10.1177/..

7

Early MRI in optic neuritis: the risk for clinically defini..:

Swanton, JK ; Fernando, KT ; Dalton, CM...
Multiple Sclerosis Journal. 16 (2010) 2 - p. 156-165 , 2010

Link: https://doi.org/10.1177/..

8

Hippocampal atrophy in relapsing-remitting and primary prog..:

Anderson, VM ; Fisniku, LK ; Khaleeli, Z....
Multiple Sclerosis Journal. 16 (2010) 9 - p. 1083-1090 , 2010

Link: https://doi.org/10.1177/..

9

Progression on the Multiple Sclerosis Functional Composite ..:

Bosma, LVAE ; Kragt, JJ ; Brieva, L....
Multiple Sclerosis Journal. 16 (2010) 7 - p. 862-867 , 2010

Link: https://doi.org/10.1177/..

10

Urinary neopterin and nitric oxide metabolites as markers o..:

Rejdak, K. ; Leary, SM ; Petzold, A....
Multiple Sclerosis Journal. 16 (2010) 9 - p. 1066-1072 , 2010

Link: https://doi.org/10.1177/..

11

Lesion enhancement diminishes with time in primary progress..:

Khaleeli, Z. ; Ciccarelli, O. ; Mizskiel, K....
Multiple Sclerosis Journal. 16 (2010) 3 - p. 317-324 , 2010

Link: https://doi.org/10.1177/..

12

The NO donor DETA‐NONOate reversibly activates an inward cu..:

Thompson, AJ ; Mander, PK ; Brown, GC
British Journal of Pharmacology. 158 (2009) 5 - p. 1338-1343 , 2009

Link: https://doi.org/10.1111/..

13

MRI measures show significant cerebellar gray matter volume..:

Anderson, VM ; Fisniku, LK ; Altmann, DR..
Multiple Sclerosis Journal. 15 (2009) 7 - p. 811-817 , 2009

Link: https://doi.org/10.1177/..

14

Magnetization transfer ratio abnormalities reflect clinical..:

Fisniku, LK ; Altmann, DR ; Cercignani, M...
Multiple Sclerosis Journal. 15 (2009) 6 - p. 668-677 , 2009

Link: https://doi.org/10.1177/..

15

The search for responsive clinical endpoints in primary pro..:

Bosma, LVAE ; Kragt, JJ ; Brieva, L...
Multiple Sclerosis Journal. 15 (2009) 6 - p. 715-720 , 2009

Link: https://doi.org/10.1177/..